MedPath

Efficacy Evaluation of SARVONUTRA M as Male Wellness Agent

Phase 2/3
Not yet recruiting
Conditions
Other male sexual dysfunction. Ayurveda Condition: KLAIBYAM,
Registration Number
CTRI/2022/05/042708
Lead Sponsor
SARVOTHAM CARE LIMITED
Brief Summary

The back ground of the trial is to evaluate the efficacy of this proprietary and patented formulation addressing the quality of life in men and sustaining a happy family life

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Male
Target Recruitment
30
Inclusion Criteria
  • a) Healthy male individuals.
  • b) Infertility and low conjugal life for more than 3 months diagnosed with oligospermia (defined by <15 million sperms/ml) as per the WHO standards c) No past history of renal, hepatic, or any other chronic illness in the past d) Normal liver, and renal function tests.
  • e) Patients freely willing and able to provide written informed consent, willing to follow study procedures.
Exclusion Criteria

a) Complete azoospermia in the pre-treatment samples b) Any congenital anomaly resulting in oligospermia c) Evidence of male accessory gland infection d) Any recent medical or surgical illness e) Hormone/any other treatment for promoting fertility in the last three months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
a) Evaluate the improvements of quality of conjugal life.6 - 8 weeks
b) Reduction in premature ejaculation6 - 8 weeks
c) Arousal with lesser foreplay6 - 8 weeks
d) Improvement in seminal output and motility6 - 8 weeks
e) If any conceptions during clinical trial6 - 8 weeks
Secondary Outcome Measures
NameTimeMethod
a) Changes in mood swingb) Better sleep

Trial Locations

Locations (1)

KARNATAKA AYURVEDA MEDICAL COLLEGE

🇮🇳

Kannada, KARNATAKA, India

KARNATAKA AYURVEDA MEDICAL COLLEGE
🇮🇳Kannada, KARNATAKA, India
Dr Ravi
Principal investigator
9945898138
kamc.kect@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.